QIAGEN NV's ticker is QGEN and the CUSIP is N72482123. A total of 17 filers reported holding QIAGEN NV in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2018 | $79,285,000 | +12.8% | 2,176,055 | +0.0% | 0.02% | +10.0% |
Q1 2018 | $70,268,000 | +3.4% | 2,175,877 | 0.0% | 0.02% | 0.0% |
Q4 2017 | $67,944,000 | -0.8% | 2,175,877 | 0.0% | 0.02% | -4.8% |
Q3 2017 | $68,516,000 | -5.3% | 2,175,877 | 0.0% | 0.02% | -8.7% |
Q2 2017 | $72,381,000 | +14.6% | 2,175,877 | 0.0% | 0.02% | +15.0% |
Q1 2017 | $63,161,000 | -0.4% | 2,175,877 | -3.7% | 0.02% | -4.8% |
Q4 2016 | $63,393,000 | – | 2,259,565 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Hardman Johnston Global Advisors LLC | 4,177,260 | $158,235,000 | 6.82% |
Exane Asset Management | 522,037 | $19,742,931,000 | 6.18% |
Tikvah Management LLC | 442,942 | $16,779,000 | 5.01% |
Opus Point Partners Management, LLC | 31,620 | $1,198,000 | 2.86% |
EDMOND DE ROTHSCHILD HOLDING S.A. | 2,600,672 | $98,144,000 | 2.79% |
RTW INVESTMENTS, LP | 775,324 | $29,369,000 | 1.76% |
SANDLER CAPITAL MANAGEMENT | 787,529 | $29,832,000 | 1.51% |
FRIESS ASSOCIATES LLC | 531,900 | $20,148,000 | 1.40% |
Sivik Global Healthcare LLC | 85,000 | $3,220,000 | 1.15% |
Parametrica Management Ltd | 11,940 | $452,000 | 0.99% |